CARLSBAD, Calif., May 22, 2025 /PRNewswire/ -- Pictor, a global leader in multiplex proteomics solutions, is excited to announce the establishment of its U.S. headquarters in Carlsbad, California, ...
New research highlights the Pictor PictVet™ Mycoplasma bovis IgG Multiplex ELISA's enhanced analytical performance through multiplexing and its potential to enhance global disease management. "By ...
LOS ANGELES--(BUSINESS WIRE)--Following a recent funding round raising $6.1 million (NZD $8.8 million), biotech company Pictor today announced it has received confirmation of CE registration for its ...
World-leading COVID-19 antibody test developed by Auckland diagnostic biotech company Pictor will be available for use in New Zealand before the end of November, the company has announced. The test ...
The partnership will incorporate SCIENION’s CL2 sciREADER system into the PictArray SARS-CoV-2 Serology Test which will shortly begin clinical trials for FDA EUA market clearance Auckland-based ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results